An unorthodox proposal for funding primary prevention.

Examining the literature in opposition to primary prevention finds that a major issue is the unwillingness of treatment advocates to share funding with primary prevention advocates. The author describes a model of financing prevention programs through the private sector, explains the methods necessary to implement the model, and provides three examples of prevention initiatives where the model can be applied. The paper ends with a discussion of the model's strengths and weaknesses.